Drawing for DELTA G

USPTO serial 79244399

DELTA G

Reviewed by CopyMark Law Group

Status 603
Filing date
Status date
Registration date
—
Examiner
MCBRIDE, CAMERON L
Law office
TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DELTA G?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

REBECCA L WILSON

REBECCA L WILSON THE DOBRUSIN LAW FIRM PC29 WEST LAWRENCE STREET, SUITE 210PONTIAC, MI 48342UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Caloric substitutes for carbohydrates in the nature of nutritional supplements used to maintain, promote and enhance health, wellness and fitness and to treat medical conditions, namely, alzheimer's disease, parkinson's disease, depression, muscular conditions, treating, preventing or aiding recovery from fatigue, improving muscle function efficiency and muscular power, maintaining and improving cognitive function, raising blood ketone levels in the human or animal body, diabetes or disorder of glucose metabolism, cachexia, neuro-degenerative conditions, muscular dystrophic states, increasing metabolic efficiency, reducing fatigue, reducing muscle damage or wasting, inflammatory diseases and radiation damage, as well as epilepsy, anxiety, dementia, cancer, and cell damage; substances in the nature of nutritional and dietary supplements for the treatment of muscle fatigue, muscle conditions, epilepsy, anxiety, dementia, cancer, cachexia and cell damage and substances for improving cognitive function and raising ketone blood levels in humans or animals; all the aforementioned containing ketone esters or hydroxybutyrates as an integrated component ingredientACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 20, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 5, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 22, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 12, 2021FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 23, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 23, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 23, 2020MAB3ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL—
Nov 19, 2020ABN3ABANDONMENT - AFTER EX PARTE APPEAL—
Nov 19, 2020EXPTEXPARTE APPEAL TERMINATED—
Aug 25, 2020EXPAEX PARTE APPEAL-REFUSAL AFFIRMED—
May 23, 2020RBFTREPLY BRIEF FILED - CHECK TTAB FILES—
Apr 28, 2020GNSNNOTIFICATION OF EXAMINERS STATEMENT E-MAILED—
Apr 28, 2020GNESEXAMINERS STATEMENT E-MAILED—
Apr 28, 2020CNESEXAMINERS STATEMENT - COMPLETED—
Apr 17, 2020OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 1, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 1, 2020OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 13, 2020JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jan 6, 2020GEA1NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED—
Jan 6, 2020GECDACTION DENYING REQ FOR RECON E-MAILED—
Jan 6, 2020CNCFACTION CONTINUING FINAL - COMPLETED—
Dec 27, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 26, 2019ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Dec 26, 2019EXPIEX PARTE APPEAL-INSTITUTED—
Dec 26, 2019JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Dec 26, 2019EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Jul 25, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 25, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 25, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 25, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 4, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 3, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 3, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 3, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 3, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 21, 2018RFNTREFUSAL PROCESSED BY IB—
Dec 1, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 1, 2018RFRRREFUSAL PROCESSED BY MPU—
Nov 15, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 14, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 13, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 7, 2018DOCKASSIGNED TO EXAMINER—
Nov 7, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 1, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance